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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
23.06.2020 SARS 
CoV-2 
serosurvey 
in Addis 
Ababa, 
Ethiopia 
medRxiv 
(non-peer 
reviewed) | 
pre-print 
 3 out of 99 asymptomatic 
people recruited from a clinical 
laboratory in the general 
population in May, 2020 in 
Addis Ababa tested positive 
for SARS-CoV-2 IgG 
 Plausible population 
prevalence values range from 
1.0 to 8% when taking into 
account pre-test probability 
and the sampling scheme 
 Results suggest that the large 
majority of the general 
population in Addis Ababa are 
currently susceptible to 
COVID-19 
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Social Science 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
24.06.2020 Knowledge, 
attitude, 
perceptions 
and 
practice 
towards 
COVID-19: 
a 
systematic 
review and 
meta-
analysis 
medRxiv 
(non-peer 
reviewed) | 
pre-print 
 This study summarises the 
level of risk reduction 
practices about C19 through 
systematic review 
 Lack of C19-relted 
knowledge, positive 
perceptions, and preventive 
practices was detected and 
seems widespread 
 Evidence-based practices on 
risk communication and 
raising awareness should be 
planned by local governments 
in collaboration with 
healthcare organisations 
 Educational initiatives for 
HCWs to wear a face mask 
and practicing hand hygiene 
should be prioritised 
Knowledge, 
attitude, 
perception 
  
Health systems 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
 23.06.2020 Cost-
effectiveness 
and return on 
investment of 
protecting 
health 
workers in 
low- and 
middle-
income 
countries 
during the 
COVID-19 
pandemic 
 medRxiv 
(non-peer 
reviewed) | 
pre-print 
 LMICs, regional and 
national estimates of 
mortality for HCWs, 
cost-effectiveness and 
return on investment 
are presented  
 Wide-scale 
procurement and 
distribution of PPE for 
LMICs is essential to 
prevent widespread 
HCW morbidity and 
mortality. It is cost-
effective and yields a 
large downstream 
return on investment  
HCW, cost-
effectiveness, 
ROI 
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Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article 
type 
Author(s) 
July 2020 Africa’s COVID-19 health technologies’ 
watershed moment 
The Lancet 
Digital Health | 
News 
Paul Adepoju 
24.06.2020 Globalisation in the time of COVID-19: 
repositioning Africa to meet the immediate 
and remote challenges 
Globalization 
and Health | 
Commentary 
Sanni Yaya et cl 
24.06.2020 Commercial influence and covid-19 BMJ | Editorial  
24.06.2020 From Ebola to COVID-19: How Uganda 
can adapt its response to the current crisis 
Health Policy 
and Planning 
Debated | Blog 
Federica Margini 
Anooj Pattnaik 
Angellah 
Nakyanzi 
23.06.2020 Beyond COVID-19 (coronavirus): What 
will be the new normal for health systems 
and universal health coverage? 
World Bank | 
Blog 
Agnes Soucat 
Francesca 
Colombo 
Feng Zhao 
23.06.2020 Besides population age structure, health 
and other demographic factors can 
contribute to understanding the COVID-19 
burden 
PNAS | Letter Marilia R. 
Nepomyceno et 
al. 
23.06.2020 In poor countries, many Covid-19 patients 
are desperate for oxygen 
NY Times | 
Global Health 
News 
Donald G. McNeil 
23.06.2020 The colliding epidemics of COVID-19, 
Ebola, and measles in the Democratic 
Republic of the Congo 
The Lancet 
Global Health | 
Comment 
Jean B Nachega 
et al 
4 
23.06.2020 COVID-19 scientific and public health 
policy update (23 June 2020) 
Africa CDC  
22.06.2020 COVID-19 & violence against women and 
children: what have we learned to far? 
CGD | Notes Amber Peterman 
Megan O’Donnell 
Tia Palermo 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence & 
policy maps 
Current 
research 
including trials 
  Diagnostics  Treatments   Vaccines 
WHO sitreps WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-CoV-
2 Test 
Tracker 
  Global 
COVID-19 
Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Arguments 
Indonesia EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-CoV-
2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based tests 
for COVID-
19 
  Solidarity 
trial 
 COVID-
19 Oxford 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: C19 
Testing 
  COVID-19 
Therapeutics 
Accelerator 
  
Our World in 
Data 
  Singapore  Our World 
in Data: 
C19 Policy 
responses 
COVID-
evidence 
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Global 5050 
  UK  IFPRI 
COVID-19 
Policy 
Response 
Portal 
Cochrane       
CEBM, 
University of 
Oxford 
  US  COVID-19 
Primer 
Clinicaltrials.gov       
Humanitarian 
Data 
Exchange 
     NIH 
LitCovid 
 UKCDR       
Information 
is Beautiful 
     WHO 
COVID-19 
Database 
        
LSHTM               
HealthMap 
(cases) 
              
The 
Commons 
Project 
              
C19 Resource Hubs 
Global  Regional & 
Country 
Academic 
journals & 
Publishers 
Institutes/Centres
/Funders/Other 
Health 
Topics 
  Social 
Sciences 
WHO COVID-
19 pandemic  
Africa CDC Annals of 
Internal 
Medicine 
LSTM Stop TB 
Partnership 
  SSHAP 
WHO risk 
communication 
African 
Union 
BMJ LSHTM 
 
  IDA 
6 
WHO Q&A Nigeria 
CDC 
Bulletin of 
the WHO 
ICL MRC Centre 
for Global 
Infectious 
Disease Analysis 
Global 
Menstrual 
Collective  
  Disability and 
inclusion 
WHO Global 
research 
GeoPoll: 
SSA 
Cambridge 
University 
Press 
ODI SLH: 
Handwashin
g in low 
resource 
settings 
  Coregroup 
IDDC 
COVID-19 
Solidarity 
Response Fund 
Global 
Health 
Network 
Africa 
Cell Press Johns Hopkins 
University 
RBM 
Partnership 
  Ethics, health 
systems & 
COVID-19 
UN African 
Academy of 
Sciences 
Cochrane  Center for Global 
Development 
    Social 
Development 
Direct C19 
blog series 
UN Women Africa 
Evidence 
Network 
Elsevier CMMID 
Repository 
    
UNOCHA OCHA 
Southern 
and Eastern 
Africa 
COVID-19 
Digest 
JAMA 
Network 
Norwegian 
Institute of Public 
Health 
    
UNHCR  South 
African 
Government 
The 
Lancet 
Oxford Centre for 
Evidence-based 
Medicine 
    
UNICEF   medRxiv 
and 
bioRxiv 
(Preprints) 
 HEART     
UNESCO   NEJM  UKRI     
7 
UN WFP   Oxford 
University 
Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources 
and Analyses of 
C19 Impact 
    
World Bank   Science  Prevent 
Epidemics  
    
Our World in 
Data 
  Springer 
Nature 
      
COVID-19 
Narratives by 
David Nabarro 
  SSRN 
(Preprints)  
      
Reliefweb   Wiley       
Humanitarian 
OpenStreetMap 
Team 
          
Global 
Partnership for 
Sustainable 
Development 
Data 
  
 
      
WorldPop           
Flowminder           
COVID-END           
Premise 
COVID-19 
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Global Impact 
Study 
GISAID           
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
26.06.2020 
0900 to 
1030 EDT 
Monitoring and 
mitigating the 
collateral effects of 
COVID-19 
Online event 1h 30 CGD 
13 July 3:00 
PM – 6:00 
PM BST 
2020 UCL-Lancet 
Lecture: Global 
Health Preparedness 
by Dr Muhammad 
Pate, Global Director 
for Health, Nutrition 
and Population at the 
World Bank Group 
Online Lecture  2 hour 
lecture, 1 
hour panel 
discussion 
UCL, The Lancet 
June 2020 OpenWHO, the free, 
open-access learning 
platform for health 
emergencies, now 
offers 10 online 
courses related to 
COVID19. 
Online 
courses 
Varies WHO 
24-
25.06.2020 
Africa’s leadership 
role in COVID-19 
vaccine development 
and access 
Zoom webinar   African Union & Africa 
CDC 
Available 
now 
Standard 
precautions: 
Environmental 
cleaning and 
disinfection 
Online course 1 hour WHO 
9 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 2 
hours per 
week 
Johns Hopkins School 
of Nursing 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, 
Modelling and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
12.05.2020 COVID-19 and 
maintaining quality 
essential health 
services  
Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr Peter 
Lachman, Dr Teri 
Rynolds & Dr Ed 
Kelley 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
Online 
learning 
3 hours WHO 
10 
for detection, 
prevention, response 
and control 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple self-
paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel 
Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple self-
paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
